Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Simona Amodeo
Institution:
Azienda di Rilievo Nazionale ed Alta Specializzazione
Observed institutions:
Mario Negri Institute for Pharmacological Research,
Azienda di Rilievo Nazionale ed Alta Specializzazione,
University of Palermo
ORCID:
0000-0002-2980-7372
Observed ORCID:
0000-0002-2980-7372
OpenAlex ID:
A5028050850
The Role of Vitamin D and Its Molecular Bases in Insulin Resistance, Diabetes, Metabolic Syndrome, and Cardiovascular Disease: State of the Art
2023
·
Christiano Argano
, Luigi Mirarchi
, et al.
·
International Journal of Molecular Sciences
·
294
PDF
SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease
2022
·
Luigi Mirarchi
, Simona Amodeo
, et al.
·
International Journal of Molecular Sciences
·
44
PDF
Metabolic dysfunction-associated steatotic liver disease: A pathophysiology and clinical framework to face the present and the future
2024
·
Salvatore Corrao
, Luigi Calvo
, et al.
·
Nutrition Metabolism and Cardiovascular Diseases
·
30
Can Baseline IL-6 Levels Predict Long COVID in Subjects Hospitalized for SARS-CoV-2 Disease?
2023
·
Lydia Giannitrapani
, Luigi Mirarchi
, et al.
·
International Journal of Molecular Sciences
·
25
PDF
The Changing Epidemiology of Hepatocellular Carcinoma : Experience of a Single Center
2020
·
Lydia Giannitrapani
, Maddalena Zerbo
, et al.
·
BioMed Research International
·
25
PDF
Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome
2024
·
Roberto Citarrella
, Roberta Chianetta
, et al.
·
Nutrients
·
17
PDF
Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population
2022
·
Lydia Giannitrapani
, Giuseppa Augello
, et al.
·
Journal of Infection
·
14
PDF
Type 2 Diabetes Mellitus Remission, Dream or Reality? A Narrative Review of Current Evidence and Integrated Care Strategies
2025
·
Salvatore Corrao
, Fabio Falcone
, et al.
·
Diabetes Therapy
·
13
PDF
Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort
2021
·
Anna Licata
, Maria Giovanna Minissale
, et al.
·
Internal and Emergency Medicine
·
9
PDF
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis
2024
·
Nicola Veronese
, Francesco Di Gennaro
, et al.
·
Scientific Reports
·
8
PDF
Beyond inflammation: metabolic implications of biological and TsDMARD therapies in dermatologic and rheumatologic diseases
2026
·
Salvatore Corrao
, Salvatore Scibetta
, et al.
·
Frontiers in Immunology
·
5
PDF
EVOO’s Effects on Incretin Production: Is There a Rationale for a Combination in T2DM Therapy?
2022
·
Simona Amodeo
, Luigi Mirarchi
, et al.
·
International Journal of Molecular Sciences
·
5
PDF
Adaptive evidence-based medicine in type 2 diabetes: beyond the average effect toward personalised clinical decision-making for a humanised medicine
2026
·
Salvatore Corrao
, Salvatore Scibetta
, et al.
·
Diabetes Research and Clinical Practice
·
4
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort
2021
·
Maria Giovanna Quaranta
, Luigina Ferrigno
, et al.
·
Digestive and Liver Disease
·
4
PDF
Changes in the ultrasound presentation of hepatocellular carcinoma: a center’s three decades of experience
2024
·
Lydia Giannitrapani
, Simona Amodeo
, et al.
·
Journal of Ultrasound
·
2
PDF
COVID in 2022. Clinical risk management of sars-cov-2 positive patients admitted to an internal medicine ward
2022
·
Anna Licata
, Simona Amodeo
, et al.
·
Clinical and Experimental Medicine
·
2
PDF
Prescription of SGLT-2 inhibitors alone or in combination with RAS-inhibitors in patients with diabetes mellitus and comorbid cardiovascular disease, chronic kidney disease or cardiorenal disease: a real-world evidence study from the REPOSI registry
2026
·
Paolo Lido
, Sara Ratti
, et al.
·
Internal and Emergency Medicine
Exercise as targeted therapy in type 2 diabetes: a phenotype-informed clinical prioritisation framework for adapted physical activity
2026
·
Salvatore Corrao
, Salvatore Scibetta
, et al.
·
Diabetes Research and Clinical Practice
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry
2025
·
Chiara Elli
, Alessio Novella
, et al.
·
Internal and Emergency Medicine
De-novo occurrence of portal vein thrombosis in patients with HCV-related cirrhosis after sustained virological response: medium to long term observations from the ongoing PITER cohort
2022
·
Loreta Kondili
, Maria Giovanna Quaranta
, et al.
·
Journal of Hepatology
Modificazioni Ecografiche Della Linfadenopatia Dell’ilo Epatico Dopo Eradicazione Dell’hcv Con Direct-acting Antivirals
2019
·
Lydia Giannitrapani
, Antonino Terranova
, et al.
Presentazione Ecografica Dell’epatocarcinoma: Esperienza Di Un Singolo Centro Nell’arco Di Tre Decenni
2019
·
Lydia Giannitrapani
, Giuseppe Brancatelli
, et al.
Show more works
View as search
Works count:
22
Citation count:
501
H-index:
9
I10-index:
8
Year
Topic
Type